Dr. Colleen McCormick's guide to understanding PARP inhibitors and ovarian cancer.
Welcome to Dr. Colleen McCormick‘s guide to understanding PARP inhibitors and ovarian cancer.
Dr. McCormick, from Legacy Cancer Institute, has collaborated with SurvivorNet for this resource. People in the ovarian cancer community tell us that hearing advice like this, and knowing the options, has helped them make better decisions and reduce anxiety.
Dr. Colleen McCormick
Ovarian cancer specialists around the country are increasingly excited about the new treatment possibility of PARP inhibitors, and one reason is that more and more research is finding that there is some benefit for many different kinds of patients.
Dr. Colleen McCormick
To determine when — and whether — you are eligible for one of these promising drugs, your gynecologic oncologist will likely recommend a series of tests to see whether your cancer cells have the right characteristics, and to what degree.
